Cargando…
Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors
T cells provide essential immunosurveillance to combat and eliminate infection from pathogens, yet these cells can also induce unwanted immune responses via T cell receptor (TCR) cross-reactivity, also known as heterologous immunity. Indeed, pathogen-induced TCR cross-reactivity has shown to be a co...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042382/ https://www.ncbi.nlm.nih.gov/pubmed/32140156 http://dx.doi.org/10.3389/fimmu.2020.00248 |
_version_ | 1783501299057164288 |
---|---|
author | Rowntree, Louise C. van den Heuvel, Heleen Sun, Jessica D'Orsogna, Lloyd J. Nguyen, Thi H. O. Claas, Frans H. J. Rossjohn, Jamie Kotsimbos, Tom C. Purcell, Anthony W. Mifsud, Nicole A. |
author_facet | Rowntree, Louise C. van den Heuvel, Heleen Sun, Jessica D'Orsogna, Lloyd J. Nguyen, Thi H. O. Claas, Frans H. J. Rossjohn, Jamie Kotsimbos, Tom C. Purcell, Anthony W. Mifsud, Nicole A. |
author_sort | Rowntree, Louise C. |
collection | PubMed |
description | T cells provide essential immunosurveillance to combat and eliminate infection from pathogens, yet these cells can also induce unwanted immune responses via T cell receptor (TCR) cross-reactivity, also known as heterologous immunity. Indeed, pathogen-induced TCR cross-reactivity has shown to be a common, robust, and functionally potent mechanism that can trigger a spectrum of human immunopathologies associated with either transplant rejection, drug allergy, and autoimmunity. Here, we report that several virus-specific CD8(+) T cells directed against peptides derived from chronic viruses (EBV, CMV, and HIV-1) presented by high frequency HLA-A and -B allomorphs differentially cross-react toward HLA-B27 allotypes in a highly focused and hierarchical manner. Given the commonality of cross-reactive T cells and their potential contribution to adverse outcomes in allogeneic transplants, our study demonstrates that multiple antiviral T cells recognizing the same HLA allomorph could pose an extra layer of complexity for organ matching. |
format | Online Article Text |
id | pubmed-7042382 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70423822020-03-05 Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors Rowntree, Louise C. van den Heuvel, Heleen Sun, Jessica D'Orsogna, Lloyd J. Nguyen, Thi H. O. Claas, Frans H. J. Rossjohn, Jamie Kotsimbos, Tom C. Purcell, Anthony W. Mifsud, Nicole A. Front Immunol Immunology T cells provide essential immunosurveillance to combat and eliminate infection from pathogens, yet these cells can also induce unwanted immune responses via T cell receptor (TCR) cross-reactivity, also known as heterologous immunity. Indeed, pathogen-induced TCR cross-reactivity has shown to be a common, robust, and functionally potent mechanism that can trigger a spectrum of human immunopathologies associated with either transplant rejection, drug allergy, and autoimmunity. Here, we report that several virus-specific CD8(+) T cells directed against peptides derived from chronic viruses (EBV, CMV, and HIV-1) presented by high frequency HLA-A and -B allomorphs differentially cross-react toward HLA-B27 allotypes in a highly focused and hierarchical manner. Given the commonality of cross-reactive T cells and their potential contribution to adverse outcomes in allogeneic transplants, our study demonstrates that multiple antiviral T cells recognizing the same HLA allomorph could pose an extra layer of complexity for organ matching. Frontiers Media S.A. 2020-02-19 /pmc/articles/PMC7042382/ /pubmed/32140156 http://dx.doi.org/10.3389/fimmu.2020.00248 Text en Copyright © 2020 Rowntree, van den Heuvel, Sun, D'Orsogna, Nguyen, Claas, Rossjohn, Kotsimbos, Purcell and Mifsud. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Rowntree, Louise C. van den Heuvel, Heleen Sun, Jessica D'Orsogna, Lloyd J. Nguyen, Thi H. O. Claas, Frans H. J. Rossjohn, Jamie Kotsimbos, Tom C. Purcell, Anthony W. Mifsud, Nicole A. Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors |
title | Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors |
title_full | Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors |
title_fullStr | Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors |
title_full_unstemmed | Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors |
title_short | Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8(+) T Cell Receptors |
title_sort | preferential hla-b27 allorecognition displayed by multiple cross-reactive antiviral cd8(+) t cell receptors |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042382/ https://www.ncbi.nlm.nih.gov/pubmed/32140156 http://dx.doi.org/10.3389/fimmu.2020.00248 |
work_keys_str_mv | AT rowntreelouisec preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors AT vandenheuvelheleen preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors AT sunjessica preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors AT dorsognalloydj preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors AT nguyenthiho preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors AT claasfranshj preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors AT rossjohnjamie preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors AT kotsimbostomc preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors AT purcellanthonyw preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors AT mifsudnicolea preferentialhlab27allorecognitiondisplayedbymultiplecrossreactiveantiviralcd8tcellreceptors |